Top Glove, Other Glove Makers Soar on Omicron Fears
Top Glove, Other Glove Makers Soar on Omicron Fears
By Chester Tay
作者：切斯特·泰(Chester Tay)
KUALA LUMPUR, Malaysia--Shares of Malaysia's Top Glove Corp. soared in Monday trading as global concerns mount over the Covid-19 Omicron variant, though analysts said the boost could be short-lived.
馬來西亞吉隆坡-馬來西亞頂級手套公司(Top Glove Corp.)的股價週一在交易中飆升，原因是全球對新冠肺炎奧米克隆(Omicron)的擔憂加劇，儘管分析人士表示，這一提振可能是短暫的。
Shares of the world's largest glove maker by capacity rose by as much as 30% to MYR3.43, hitting the Malaysian bourse's maximum limit and briefly putting Top Glove on pace for its biggest one-day gain since listing 20 years ago. The company's shares were last up 20%, trimming year-to-date losses to 48%.
這家全球產能最大的手套製造商的股價一度上漲30%，至3.43馬幣，觸及馬來西亞證交所的最高漲幅上限，並短暫推動Top Glove創下20年前上市以來的最大單日漲幅。該公司股價最後一次上漲20%，將今年迄今的虧損減少到48%。
Other regional glove companies rallied as well, with Hartalega Holdings Bhd. climbing 21%, Kossan Rubber Industries Bhd. up 11% and Supermax Corp. gaining 22% in late afternoon trading. Singapore-listed Riverstone Holdings Ltd. rose 15%.
其他地區性手套公司也出現上漲，Hartalega Holdings Bhd。高山橡膠工業公司(Kossan Rubber Industries Bhd)股價上漲21%。在下午晚些時候的交易中，上漲了11%，Supermax Corp.上漲了22%。在新加坡上市的Riverstone Holdings Ltd.上漲15%。
Malacca Securities senior analyst Kenneth Leong said buying interest in glove stocks may not be as sustainable as it was during the first global outbreak last year.
馬六甲證券(Malacca Securities)高級分析師Kenneth Leong表示，對手套類股的買興可能不像去年第一次全球疫情期間那樣可持續。
"Pharmaceutical companies have indicated that they are capable of producing large amount of vaccines against this new variant, while governments have been quick to impose containment measures," he said.
他説：“製藥公司已經表示，他們有能力生產大量針對這種新變種的疫苗，而各國政府也迅速採取了遏制措施。”
TA Securities added that although news of the variant could increase speculative interest in healthcare stocks--especially in what it described as undervalued Kossan Rubber and Hartalega--it doesn't expect the global economic recovery to be derailed given vaccinations that could minimize the chances of hospitalization or death. TA has buy ratings on both Kossan and Hartalega.
TA Securities補充説，儘管這種變種的消息可能會增加人們對醫療保健類股的投機興趣，特別是它所説的被低估的Kossan Rubber和Hartalega，但該公司預計，鑑於疫苗接種可能會將住院或死亡的可能性降至最低，全球經濟復甦不會脱軌。TA對Kossan和Hartalega都有買入評級。
Top Glove's stock soared multiple times over in 2020 but has fallen this year on concerns about waning demand for protective wear and middling average selling prices, as the pandemic appeared to be coming under control.
Top Glove的股價在2020年飆升了數倍，但由於擔心防護服需求減弱和平均售價中等，隨着疫情似乎得到控制，該公司股價今年有所下跌。
Write to Chester Tay at chester.tay@wsj.com
寫信給Chester Tay，郵箱是chester.tay@wsj.com
譯文內容由第三人軟體翻譯。